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RESUMO – A seleção de isolados fúngicos resistentes aos tratamentos disponíveis associada a um aumento no número de 
pacientes imunossuprimidos contribui para a incidência de infecções causadas por fungos demáceos. Assim, este estudo 
avaliou a eficácia terapêutica dos principais antifúngicos atualmente utilizados na prática clínica em relação à Curvularia 
spp. e Hortaea werneckii de casos de feohifomicose superficiais do sul do Brasil. O perfil de suscetibilidade para anfoterici-
na B, fluconazol, itraconazol, terbinafina e voriconazol foi avaliado por microdiluição em caldo frente a fungos demáceos 
(Curvularia lunata, C. pallescens e H. werneckii). A terbinafina demonstrou maior eficácia contra C. lunata - média gemomé-
trica (GM = 0,38 μg/mL), C. pallescens (MIC = 0,125 μg/mL) e H. werneckii (GM = 0,031 μg/mL) quando comparado aos 
demais antifúngicos testados. A maioria das espécies apresentou sensibilidade ao itraconazol e ao voriconazol, com uma 
concentração inibitória mínima (CIM) variando entre 1 - 8,0 μg/mL e 0,5 - 2,0 μg/mL, respectivamente. Todos os isolados 
testados apresentaram menor sensibilidade ao fluconazol (faixa de CIM 4 - 16 μg/mL). Embora o itraconazol seja conside-
rado padrão ouro, a terbinafina demonstrou ser uma ótima alternativa para o tratamento das feohifomicose superficiais. O 
teste de suscetibilidade antifúngica é essencial para indicar a terapia ideal frente a essas infecções.
PALAVRAS-CHAVE – Antifúngicos; Brasil; Farmacorresistência Fúngica; Feoifomicose.
In vitro Antifungal Susceptibility of Agents for 
Superficial Phaeohyphomycosis 
ABSTRACT – The selection of fungal isolates resistant to available therapy associated with an increase in the number of immu-
nosuppressed patients has contributed to the incidence of infections caused by dematiaceous fungi. Thus, this study evaluated 
the therapeutic efficacy of the main antifungal agents currently used in clinical practice in relation to Curvularia spp. and Hor-
taea werneckii from cases of superficial phaeohyphomycosis from southern Brazil. The susceptibility profile of amphotericin 
B, fluconazole, itraconazole, terbinafine and voriconazole against dematiaceous fungi (Curvularia lunata, C. pallescens and 
H. werneckii) was evaluated by microdilution in broth. Terbinafine showed greater efficacy against C. lunata - gemometric 
mean (GM = 0.38 μg/mL), C. pallescens (MIC = 0.125 μg/mL) and H. werneckii (GM = 0.031 μg/mL) when compared to 
the other antifungals tested.  Most of species showed sensitivity to itraconazole and voriconazole, with a minimum inhibitory 
concentration (MIC) range from 1 - 8.0 μg/mL and 0.5 - 2.0 μg/mL, respectively. All isolates tested show low sensitivity to 
fluconazole (MIC range 4 - 16 μg/mL). Although itraconazole is considered gold standard, terbinafine has been showed to be 
a good alternative for the treatment of superficial phaeohyphomycosis. Lastly, antifungal susceptibility testing is essential to 
indicate the ideal therapy against these infections.  
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INTRODUCTION
Dematiaceous filamentous fungi are generally found 
in humid environments, such as decaying vegetation, bird 
nests, wood and soil, covering regions of tropical and sub-
tropical climates.1 These organisms are morphologically 
characterized by the formation of dark colonies, septate 
hyphae or black-yeasts elements.2 The pigmentation of de-
matiaceous fungi is associated with the presence of melanin 
in its cell wall, which acts as an important virulence factor 
in the development of fungal infections in humans, such as 
phaeohyphomycosis.3
Ungual phaeohyphomycosis are examples of non-der-
matophytic onychomycosis, responsible for 1.5% to 18% of 
the cases of these infections.4,5 Phaeohyphomycosis have in-
creased their incidence in humans, both in immunocompro-
mised and immunocompetent individuals,6 and cause nail 
disease presenting  as changes in color, thickness, detach-
ment and onychodystrophy.7 
The genus Curvularia has a worldwide coverage that is 
mostly found in soil and in plants.2 Due to this, most cases 
of phaeohyphomycosis induced by these fungi occur in men 
aged 30-50 years, working in rural areas or other occupa-
tions that expose them to plant materials.8,9 H. werneckii, 
although with worldwide distribution, is mainly found in re-
gions of tropical and subtropical climates of Central and 
South America, Africa and Asia and in places with high salt 
concentration.10,11 This species has peculiar structural cha-
racteristics, because its yeast and filamentous forms coexist. 
Initially, colonies are restricted, black, and similar to yeast 
(yeast-like fungi)12 and over time, fungal structures become 
broad septate and dark hyphae, mostly with a filamentous 
appearance.13 Tinea nigra is a superficial phaeohyphomy-
cosis caused by H. werneckii,14 which presents as brown to 
black macules with sharp margins and irregular shapes, 
usually located on the palms and soles.11 
Treatment of dematiaceous infections can be performed 
with different classes of antifungals.13 Azoles like itraconazole 
(ITC), voriconazole (VRC) and posaconazole (PSC) are consi-
dered the first choice and most effective drugs.1,13,15 According 
to Wong & Revankar,16 generally amphotericin B (AMB) has 
satisfactory activity against most of the dematiaceous fungi 
and some studies have shown that terbinafine (TRB) is highly 
effective against these infections.14,17 On the other hand, fluco-
nazole (FLC) and ketoconazole (KTC) are poorly active against 
phaeohyphomycosis.1,16 Specifically for the genus Curvularia, 
the treatment of choice is not yet fully established. According 
to Aguas et al18 the use of AMB, miconazole (MCZ), CTC, TRB 
and ITC present satisfactory results. In parallel, studies de-
monstrate that therapy with ITC and TRB has been effective in 
cases of Tinea nigra caused by H. werneckii.19,20
Currently, the selection of fungal isolates resistant to 
available antifungals has contributed to the increase of in-
fections caused by dematiaceous fungi.21 However, reports 
involving the susceptibility profile of these fungi are scarce. 
Thus, the objective of this study was to evaluate the in vitro 
activity of the main antifungal agents against Curvularia 
spp. and H. werneckii isolates cultured from cases of super-
ficial phaeohyphomycosis.
MATERIAL AND METHODS
Fungal isolates
A total of nine isolates of dematiaceous fungi were used 
in this study: C. lunata (CLU 01, CLU 02, CLU 03, CLU 04 e 
CLU 05), C. pallescens (CPA 01) e Hortaea werneckii (HWE 
01, HWE 02 e HWE 03). The organisms are deposited in the 
collection of cultures of Laboratório de Micologia Aplicada, 
Universidade Federal do Rio Grande do Sul (Porto Alegre, 
Brazil) and were used in this study. All isolates were stored 
on potato dextrose agar (PDA) and kept at room temperatu-
re for the period necessary to perform all the tests. Candida 
albicans ATCC 18804 strain was obtained from American 
type culture collection (ATCC) and used as a strain control 
for the test. The fungal isolates were confirmed according to 
the taxonomic keys.22-24
Antifungals agents
Amphotericin B (AMB) (Anforicin B® - Cristália, São Paulo, 
Brazil), fluconazole (FLC) (Sigma, St. Louis, MO), itracona-
zole (ITC) (Janssen-Cilag Farmacêutica® - São Paulo, Brazil), 
terbinafine (TRB) (Funtyl® - Cristália, São Paulo, Brazil) and 
voriconazole (VRC) (Vfend® - Pfizer, Nova York, NY) were 
used in this study. The antifungal solutions were prepared in 
RPMI broth1640 (Sigma, St. Louis, MO) at128 μg/mL (AMB, 
FLC e ITC) and 16 μg/mL (VRC e TRB) according to Clinical 
and Laboratory Standards Institute (CLSI, 2008). Stock solu-
tions were prepared and stored at - 20°C until use. 
Antifungal susceptibility testing
Curvularia spp. and H. werneckii isolates were culti-
vated in Potato Dextrose Agar (Kasvi, Paraná, Brazil) and 
incubated at 32°C for 5-7 days. Then, suspensions contai-
ning these isolates were prepared in a sterile saline solution 
0.85%. The concentration of each fungal suspension was 
determined in a spectrophotometer (GT7220, Global Trade 
Technology) at 530 nm. The optical density varied between 
0.09 – 0.13 for H. werneckii and 0.25 – 0.3 for Curvularia 
spp., obtaining approximately 0.4 a 5 x 104 CFU/mL fur-
ther used for testing. Antifungal solutions were prepared in 
RPMI 1640 culture medium at128 μg/mL (AMB, FLC and 
ITC) and 16 μg/mL (VRC and TRB), obtaining a concentra-
tion range between 128 - 0.125 μg/mL and 16 - 0.031 
μg/mL, respectively. The microplates containing the antifun-
gal solutions and each fungal suspension were incubated at 
32°C for 2 and 5 days, for Curvularia spp. and H. werneckii, 
respectively. Minimum inhibitory concentration (MIC) was 
defined as the lowest concentration of antifungal capable 
of inhibiting 50% (FLC and ITC), 80% (TRB) and 100% (AMB 
and VRC) of fungal growth when compared to each isolate 
without treatment. The methodology followed the proposed 
by document M38 – A2.25 For the ATCC 18804 strain, the 
assay followed the protocol M27 - A3,26 with interpretation 
of the breakpoints according to protocol M27-S4.27
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RESULTS
The isolates from superficial phaeohyphomycosis were 
confirmed for the species from Laboratório de Micologia 
Aplicada (Porto Alegre, Brazil): C. lunata (n = 5), C. pal-
lescens (n = 1) e H. werneckii (n = 3). C. lunata isolates 
presented conidia containing three septa, simple septa, 
ellipsoids and light brown cells with hyaline at their ends. 
C. pallescens presented conidial isolates, containing three 
to four septa in their majority, ellipsoids to fusiformes, sub-
-hyaline to light brown coloration, with the third cell dis-
proportionally larger. H. werneckii isolates showed large, 
septate and dark hyphae with conidia of ellipsoidal aspect, 
brown and with double dark central septa. 
Different MIC were obtained for the drugs tested. TRB 
demonstrated greater efficacy against C. lunata (Geometric 
mean (GM) = 0.38 μg/mL) and H. werneckii (GM = 0.031 
μg/mL), when compared to the other antifungals. ITC was 
active against all genus evaluated (MIC range 1 to 8 μg/
mL). VRC and AMB presented satisfactory activity against the 
Curvularia spp. species. However, for two H. werneckii isola-
tes, these drugs were not very effective: VRC (MIC = 8 μg/
mL) and AMB (MIC > 64 μg/mL). For FLC, all isolates tested 
showed low sensitivity (MIC range 8 to 16 μg/mL). 
For Curvularia genus, the antifungal susceptibility was 
similar for all isolates. For C. lunata, FLC was the least acti-
ve antifungal (GM = 10.56 μg/mL), followed by ITC (GM = 
2.64 μg/mL), AMB (GM = 1.52 μg/mL), VRC (GM = 1.15 
μg/mL) and TRB was the most effective drug (GM = 0.38 
μg/mL). For C. pallescens, FLC showed lower efficacy (MIC 
= 8 μg/mL), followed by ITC (MIC = 4 μg/mL), AMB and 
VRC (MIC = 0.5 μg/mL) and TRB (MIC = 0.125 μg/mL). In 
contrast, AMB (GM = 32 μg/mL) was the least effective drug 
against H. Werneckii isolates, followed by FLC (GM = 8 μg/
mL), ITC (GM = 2 μg/mL), VRC (GM = 1.26 μg/mL) and 
TRB (GM = 0.031 μg/mL) (Table 1).
DISCUSSION 
The interpretative criteria for evaluation of susceptibility 
of dematiaceous filamentous fungi to clinically available an-
tifungals are not well established,25 due to the lack of clinical 
breakpoints defined against these fungal species in vitro. 
Thus, fungal susceptibility testing is essential for the iden-
tification of resistant isolates and indication of appropriate 
treatment against superficial phaeohyphomycosis28 which 
will depend on the severity and initial site of the infection, 
along with host factors such as chronic diseases, immuno-
compromising state and age.29  
Most dematiaceous fungi isolates were not susceptible 
to FLC (MIC between 16 to 64 μg/mL), as previously repor-
ted.4 Previous data showing MIC > 8 μg/mL suggests non-
-dermatophytic species are resistant for ITC.30 According to 
Yew et al,31 dematiaceous fungi present high susceptibility to 
AMB, ITC and VRC (MIC ≤ 1 μg/mL), however, low sensitivi-
ty to FLC (MIC ≥ 4 μg/mL).
Curvularia species showed low sensitivity to ITC and VRC 
but previous reports have shown a higher efficacy to these 
drugs (MIC range 0.004 - 2 μg/mL),7,13,15,32,33 also contras-
ting with for Da Cunha et al13 who showed low efficacy ITC 
and VRC when evaluated against some Curvularia species. 
Recent studies showed that AMB has been a good alternative 
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Tabe 1 - Minimum inhibitory concentration (MIC) values of antifungal agents against Curvularia spp. and 
Hortaea werneckii isolates. 
Isolates Antifungal
MIC range
(µg/mL)
Geometric mean
(µg/mL)
Curvularia lunata (n = 5)
AMB 0.5 – 4.0 1.52
FLC 4.0 – 16.0 10.56
ITC 1.0 – 8.0 2.64
TRB 0.125 – 1.0 0.38
VRC 0.5 – 2.0 1.15
Curvularia pallescens (n = 1)
AMB 0,5 -
FLC 8.0 -
ITC 4.0 -
TRB 0.125 -
VRC 0.5 -
Hortaea werneckii (n = 3)
AMB 16 - > 64 32.0
FLC 8.0 – 8.0 8.0
ITC 1.0 – 4.0 2.0
TRB 0.015 – 0.062 0.031
VRC 0.25 - > 8.0 1.26
AMB: amphotericin B; FLC: fluconazole; ITC: itraconazole; TRB: terbinafine; VRC: voriconazole.
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for phaeohyphomycosis (MIC < 2 μg/mL),16,28,34,35 since Cur-
vularia spp. isolates presented satisfactory sensitivity to this 
drug, but there are contradictory results.13 
Nizam et al33 and Krizsán et al35 described MIC > 8 μg/
mL for TRB against the genus Curvularia, but in contrast, our 
results demonstrated that TRB was highly effective against all 
isolates of this genus. 
ITC and VRC were effective for H. werneckii isolates. 
However, VRC had elevated MIC values to some isolates, 
whereas MIC > 8 μg/mL had not previously been shown for 
VRC against this specie.36,37 All H. werneckii isolates showed 
low sensitivity to AMB, in agreement with studies by Formoso 
et al.37 Finally, TRB was highly effective against all H. wer-
neckii isolates. 
CONCLUSION
Although there was no definitive correlation between the 
in vitro susceptibility and the clinical response to the anti-
fungals, this study may be importance to elucidate the sus-
ceptibility profile of antifungals available for the treatment 
of superficial phaeohyphomycosis. Curvularia spp. isolates 
showed greater sensitivity to available therapy when compa-
red to H. werneckii isolates. Although ITC is considered the 
first choice, TRB has been shown to be an excellent option 
for the treatment of phaeohyphomycosis. Thus, the evalua-
tion of the efficacy of antifungal agents is essential to indi-
cate the ideal therapy against these infections.
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